322 related articles for article (PubMed ID: 30047418)
1. Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in Fanconi Anemia.
Savage SA; Walsh MF
Hematol Oncol Clin North Am; 2018 Aug; 32(4):657-668. PubMed ID: 30047418
[TBL] [Abstract][Full Text] [Related]
2. Fanconi anemia and the development of leukemia.
Alter BP
Best Pract Res Clin Haematol; 2014; 27(3-4):214-21. PubMed ID: 25455269
[TBL] [Abstract][Full Text] [Related]
3. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
Mehta PA; Harris RE; Davies SM; Kim MO; Mueller R; Lampkin B; Mo J; Myers K; Smolarek TA
Cancer Genet Cytogenet; 2010 Dec; 203(2):180-6. PubMed ID: 21156231
[TBL] [Abstract][Full Text] [Related]
4. Fanconi Anemia patient with AML1 gene amplification and monosomy 7 in pre-transplant myelodysplasia (MDS) relapsing 7 years after successful allo-SCT.
Ayas M; Walter C
Bone Marrow Transplant; 2008 Oct; 42(8):555-7. PubMed ID: 18622412
[No Abstract] [Full Text] [Related]
5. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
Babushok DV; Bessler M
Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
[TBL] [Abstract][Full Text] [Related]
6. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.
Venkatraj VS; Gaidano G; Auerbach AD
Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673
[TBL] [Abstract][Full Text] [Related]
7. How I treat MDS and AML in Fanconi anemia.
Peffault de Latour R; Soulier J
Blood; 2016 Jun; 127(24):2971-9. PubMed ID: 27020090
[TBL] [Abstract][Full Text] [Related]
8. Current clinical management of Fanconi anemia.
Smith AR; Wagner JE
Expert Rev Hematol; 2012 Oct; 5(5):513-22. PubMed ID: 23146055
[TBL] [Abstract][Full Text] [Related]
9. Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry.
Rosenberg PS; Alter BP; Ebell W
Haematologica; 2008 Apr; 93(4):511-7. PubMed ID: 18322251
[TBL] [Abstract][Full Text] [Related]
10. Genetic disruption of both Fancc and Fancg in mice recapitulates the hematopoietic manifestations of Fanconi anemia.
Pulliam-Leath AC; Ciccone SL; Nalepa G; Li X; Si Y; Miravalle L; Smith D; Yuan J; Li J; Anur P; Orazi A; Vance GH; Yang FC; Hanenberg H; Bagby GC; Clapp DW
Blood; 2010 Oct; 116(16):2915-20. PubMed ID: 20606166
[TBL] [Abstract][Full Text] [Related]
11. Molecular Cytogenetic Approach to Characterize Novel and Cryptic Chromosome Abnormalities in Childhood Myeloid Malignances of Fanconi Anemia.
Borges ML; Capela de Matos RR; Amaral BD; Soares-Ventura EM; Leite EP; Silva MO; Cornélio MT; Silva ML; Liehr T; Marques-Salles TD
J Pediatr Hematol Oncol; 2017 Mar; 39(2):e85-e91. PubMed ID: 28212262
[TBL] [Abstract][Full Text] [Related]
12. Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms.
Chao MM; Thomay K; Goehring G; Wlodarski M; Pastor V; Schlegelberger B; Schindler D; Kratz CP; Niemeyer C
Klin Padiatr; 2017 Nov; 229(6):329-334. PubMed ID: 29132164
[TBL] [Abstract][Full Text] [Related]
13. RUNX1 mutations mitigate quiescence to promote transformation of hematopoietic progenitors in Fanconi anemia.
Marion W; Koppe T; Chen CC; Wang D; Frenis K; Fierstein S; Sensharma P; Aumais O; Peters M; Ruiz-Torres S; Chihanga T; Boettcher S; Shimamura A; Bauer DE; Schlaeger T; Wells SI; Ebert BL; Starczynowski D; da Rocha EL; Rowe RG
Leukemia; 2023 Aug; 37(8):1698-1708. PubMed ID: 37391485
[TBL] [Abstract][Full Text] [Related]
14. Fanconi anemia: current management.
Kook H
Hematology; 2005; 10 Suppl 1():108-10. PubMed ID: 16188650
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous abrogation of the G₂DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients.
Ceccaldi R; Briot D; Larghero J; Vasquez N; Dubois d'Enghien C; Chamousset D; Noguera ME; Waisfisz Q; Hermine O; Pondarre C; Leblanc T; Gluckman E; Joenje H; Stoppa-Lyonnet D; Socié G; Soulier J
J Clin Invest; 2011 Jan; 121(1):184-94. PubMed ID: 21183791
[TBL] [Abstract][Full Text] [Related]
16. Clinical, genetic and cytogenetic study of Fanconi anemia in an Indian population.
Korgaonkar S; Ghosh K; Vundinti BR
Hematology; 2010 Feb; 15(1):58-62. PubMed ID: 20132664
[TBL] [Abstract][Full Text] [Related]
17. Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor.
Tönnies H; Huber S; Kuhl JS; Gerlach A; Ebell W; Neitzel H
Blood; 2003 May; 101(10):3872-4. PubMed ID: 12511406
[TBL] [Abstract][Full Text] [Related]
18. Fanconi anemia presenting as acute myeloid leukemia: a case report.
Bhatia A; Dash S; Varma N; Marwaha RK
Indian J Pathol Microbiol; 2007 Apr; 50(2):441-3. PubMed ID: 17883104
[TBL] [Abstract][Full Text] [Related]
19. The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations.
Myers K; Davies SM; Harris RE; Spunt SL; Smolarek T; Zimmerman S; McMasters R; Wagner L; Mueller R; Auerbach AD; Mehta PA
Pediatr Blood Cancer; 2012 Mar; 58(3):462-5. PubMed ID: 21548014
[TBL] [Abstract][Full Text] [Related]
20. Incidence of malignancy and clonal chromosomal abnormalities in Fanconi anemia.
Vundinti BR; Korgaonkar S; Ghosh K
Indian J Cancer; 2010; 47(4):397-9. PubMed ID: 21131752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
